These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Calcium antagonists and treatment of chronic heart failure]. Lanfranchi J Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):623-31. PubMed ID: 7487313 [TBL] [Abstract][Full Text] [Related]
23. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency]. de Sá ME Rev Port Cardiol; 1989; 8(7-8):547-52. PubMed ID: 2698718 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition. Bühler FR J Hypertens Suppl; 1997 Dec; 15(5):S3-7. PubMed ID: 9481610 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists. Vetrovec GW Am J Cardiol; 1994 Jan; 73(3):34A-38A. PubMed ID: 8310974 [TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials. Gheorghiade M; Benatar D; Konstam MA; Stoukides CA; Bonow RO Am J Cardiol; 1997 Oct; 80(8B):14H-27H. PubMed ID: 9372994 [TBL] [Abstract][Full Text] [Related]
27. Safety of calcium antagonists in patients with congestive heart failure. Katz S Clin Ther; 1997; 19 Suppl A():92-113. PubMed ID: 9385507 [TBL] [Abstract][Full Text] [Related]
29. [Calcium antagonists in heart failure?]. Drexler H; Just H Klin Wochenschr; 1986 Oct; 64(20):993-1002. PubMed ID: 3784463 [TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics of vasodilators. Part I. Kirsten R; Nelson K; Kirsten D; Heintz B Clin Pharmacokinet; 1998 Jun; 34(6):457-82. PubMed ID: 9646008 [TBL] [Abstract][Full Text] [Related]
31. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies]. Gattis W; O'Connor CM Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855 [TBL] [Abstract][Full Text] [Related]
32. Similarities and differences between calcium antagonists: pharmacological aspects. van Zwieten PA; Pfaffendorf M J Hypertens Suppl; 1993 Mar; 11(1):S3-11. PubMed ID: 8483019 [TBL] [Abstract][Full Text] [Related]
35. [Differential therapy with calcium antagonists]. Scholze JE Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111 [TBL] [Abstract][Full Text] [Related]
36. Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure. de Vries RJ; Dunselman PH; Chin Kon Sung UG; van Veldhuisen DJ; Corbeij HM; van Gilst WH; Lie KI Heart; 1996 Feb; 75(2):159-64. PubMed ID: 8673754 [TBL] [Abstract][Full Text] [Related]
37. Calcium channel blockers in left ventricular dysfunction or congestive heart failure. White CM Conn Med; 1997 Oct; 61(10):659-61. PubMed ID: 9375452 [No Abstract] [Full Text] [Related]
40. Clevidipine: a review of its use in the management of acute hypertension. Deeks ED; Keating GM; Keam SJ Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]